Company: PFSA
Filing Date: 2025-04-03
Form Type: S-4/A
Source: 0001213900-25-028544
Chunk: 319

Company: Profusa, Inc.
Filing Date: 2025-04-03
Form: S-4/A
Chunk 319
---
 of directors held numerous meetings, consulted with Profusa’s senior management, its financial advisors and legal counsel, and considered a wide variety of factors including, among others, the following material factors (which factors are not necessarily presented in any order of relative importance): •the merger will provide Profusa’s current stockholders with greater liquidity by owning publicly -tradedstock, and expanding both the access to capital for Profusa and the range of investors potentially available as a public company, compared to the investors Profusa could otherwise gain access to if it continued to operate as a privately -heldcompany; •the potential benefits from increased public market awareness of Profusa and its products; •the historical and current information concerning Profusa’s business, including its financial performance and condition, operations, management and pre -clinicaland clinical data; •the competitive nature of the industry in which Profusa operates; •the Profusa board of directors’ fiduciary duties to Profusa’s stockholders; •the board’s belief that this transaction provides a viable public listing strategy, and addresses the risk of the lack of an available market for an initial public offering at a later date; •the expected cash resources of the combined organization (including the ability to support the combined company’s current and planned operations); •the terms and conditions of the Merger Agreement; •certain shares of New Profusa Common Stock issued to Profusa’s stockholders will be registered on a Form S -4registration statement and will become freely tradable for Profusa’s stockholders who are not affiliates of Profusa and subject to any applicable lock -upagreements; and •the likelihood that the merger will be consummated on a timely basis. The Profusa board of directors also considered a number of uncertainties and risks in its deliberations concerning the merger and the other transactions contemplated by the Merger Agreement, including the following: •the possibility that the merger might not be completed in a timely manner or at all, and the potential adverse effect of the public announcement of the merger on the reputation of Profusa and the ability of Profusa to obtain financing in the future in the event the merger is not completed; •the costs involved in connection with completing the merger, the time and effort of Profusa senior management required to complete the merger, the related disruptions or potential disruptions to Profusa’s business operations and future prospects, including its relationships with its employees, suppliers and partners and others that do business or may do business in the future with Profusa, and related administrative challenges associated with combining the companies